Answers are grounded in this paper and cite their sources.
A 6.5-yr follow-up study is reported on a case of chronic myeloid leukemia (CML) diagnosed in 1971 in a man of age of 19 yr. At that time the Ph 1 chromosome was found in all of his bone marrow cells. After 4 yr of intermittent treatment his blood and bone marrow still showed a florid CML picture, but the karyotypes of bone marrow, blood, and spleen cells were normal. Blastic transformation occurred after 5.5 yr and was accompanied by a hyperdiploid karyotype (49,XY,+9,+ 10, + 12) without reappearance of the Ph 1 chromosome. After successful chemotherapy the karyotype again became normal. In 1977 cells with a new clonal aberration (14p+) gradually became the dominating bone marrow cell population, while the peripheral blood was compatible with CML. The 14p+ clone subsequently decreased at the expense of the 49,XY,+9,+ 10,+ 12 clone, which had reappeared in the majority of the dividing blood cells. Also, a new clonal subpopulation 45,XY,t(5p; 17q) was found in 7% of the metaphases. This coincided with the occurrence of a second blast transformation, which was treated with chemotherapy. The karyotypes of all dividing cells during the recovery from the induced severe bone marrow hypoplasia still showed the t(5p; 17q) abnormality and chromosome numbers varying from 45 to 51. In some cells additional trisomies were seen as an indication of a clonal evolution. One month before the patient’s death a fourth abnormal cell line was seen in 10% of the dividing blood cells.
No takes yet. Share an insight, caveat, or question.
Hagemeijer et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: